Abcam, ab314126, Anti-Gentamicin antibody [EPR27991-65]

Size: 20µL / 100µL / 1mL
Rabbit Recombinant Monoclonal Gentamicin antibody. Suitable for WB, Dot, IHC-P, ICC/IF, Flow Cyt (Intra), IP, cELISA and reacts with Chemical samples.
Key facts
Host species:Rabbit,
Clonality:Monoclonal,
Clone number:EPR27991-65,
Isotype:IgG,
Carrier free:No,
Applications:IHC-P, IP, Dot, WB, cELISA, Flow Cyt (Intra), ICC/IFSee reactivity dataSee the reactivity data table below for information on validated species and application combinations.,
Immunogen:The exact immunogen used to generate this antibody is proprietary information.

Product details:
Patented technology
Our RabMAb
technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to
RabMAb® patents
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- High batch-to-batch consistency and reproducibility
- Improved sensitivity and specificity
- Long-term security of supply
- Animal-free batch production
For more information, read more on
recombinant antibodies

Properties and Storage Information:
Form-Liquid, Purification technique-Affinity purification Protein A, Storage buffer-pH: 7.2 - 7.4Preservative: 0.01% Sodium azideConstituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA, Shipped at conditions-Blue Ice, Appropriate short-term storage duration-1-2 weeks, Appropriate short-term storage conditions-+4°C, Appropriate long-term storage conditions--20°C, Aliquoting information-Upon delivery aliquot, Storage information-Avoid freeze / thaw cycle

Supplementary Information:
This supplementary information is collated from multiple sources and compiled automatically.
Gentamicin is not a typical biological target but rather an aminoglycoside antibiotic used in targeting bacteria. It does not possess a protein structure with a mass as it is a compound. Gentamicin acts mechanically by binding to the 30S subunit of bacterial ribosomes causing a misreading of mRNA and disrupting protein synthesis. It mainly targets gram-negative bacteria but also shows activity against some gram-positive bacteria. Gentamicin is typically administered in settings like hospitals for treating severe infections.
Biological function summary
The main activity of this antibiotic disrupts the normal function of the bacterial ribosome. It is not a part of a complex but interacts with the ribosome complex consisting of ribosomal RNA and various ribosomal proteins. By binding to the 30S subunit gentamicin causes errors in the translation process preventing the bacteria from synthesizing necessary proteins needed for growth and proliferation.
Pathways
Disruptions caused by gentamicin impact the bacterial translation pathway significantly. It affects the elongation cycle of protein synthesis where aminoacyl-tRNA enters the ribosomal A site. The faulty incorporation of amino acids due to gentamicin's effect hinders the elongation pathway leading to nonfunctional proteins and bacterial death. This process relates components like other aminoglycoside antibiotics such as amikacin which function similarly.
Severe bacterial infections often require gentamicin intervention. It is particularly relevant in treating infections caused by Pseudomonas aeruginosa and those leading to conditions such as sepsis and complicated urinary tract infections. Proteins involved in bacterial virulence and resistance such as efflux pumps are associated with how certain bacteria may resist gentamicin action impacting its effectiveness in these diseases.